financetom
Business
financetom
/
Business
/
Red Pine Reports "Best Intersection of the Year" at Wawa Gold Project in Ontario
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Red Pine Reports "Best Intersection of the Year" at Wawa Gold Project in Ontario
Mar 20, 2025 8:29 AM

11:09 AM EDT, 03/20/2025 (MT Newswires) -- Red Pine Exploration ( RDEXF ) reported Thursday its "best intersection of the year" from four drill holes totaling 1,487 meters of assayed drill core as part of its 25,000-meter drill program at the Wawa gold project in Ontario.

Highlights include 5.68 grams per tonne (g/t) gold over 10.72 meters, including 19.05 g/t gold over 2.00 meters.

"We are excited that our drilling returned the highest grade and widest intersection from the current program and that it comes from a hole that can extend the high-grade core of the Jubilee Shear at depth by more than 600 meters," chief executive Michael Michaud said. "Our recent drilling indicates that this new shoot could extend over almost 1 kilometer along its plunge and that it remains open up- and down-plunge."

The company said a drill hole near the Parkhill Mine intersected high-grade mineralization over 300 meters away from this historic mining area.

Red Pine shares were last seen down $0.005 to $0.12 on the TSX Venture Exchange.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Vivos Therapeutics' Sleep Disorder Treatment Device Receives FDA Clearance
Vivos Therapeutics' Sleep Disorder Treatment Device Receives FDA Clearance
Sep 21, 2024
07:37 AM EDT, 09/18/2024 (MT Newswires) -- Vivos Therapeutics ( VVOS ) said Wednesday that it received the US Food and Drug Administration's 510(k) clearance for its oral medical device, which treats moderate to severe obstructive sleep apnea. The company said the noninvasive, safe, and effective device is part of its CARE line and intended for children diagnosed with obstructive...
Tilray Brands' Tilray Medical Division Launches Redecan Cannabis Brand in Australia
Tilray Brands' Tilray Medical Division Launches Redecan Cannabis Brand in Australia
Sep 21, 2024
08:14 AM EDT, 09/18/2024 (MT Newswires) -- Tilray Brands' ( TLRY ) Tilray Medical division said Wednesday that its Redecan certified medical cannabis products are now available in Australia. Tilray Medical said the products it is selling in Australia include 15g Redecan PC THC28 Purple Churro and 15g Redecan SA THC28 Space Age Cake. ...
AstraZeneca Says US FDA Approves Fasenra for Rare Vasculitis Treatment
AstraZeneca Says US FDA Approves Fasenra for Rare Vasculitis Treatment
Sep 21, 2024
07:42 AM EDT, 09/18/2024 (MT Newswires) -- AstraZeneca ( AZN ) said Wednesday that its Fasenra (benralizumab) was approved by the US Food and Drug Administration for treating adult patients with eosinophilic granulomatosis with polyangiitis, a rare and potentially fatal immune-mediated vasculitis. The approval was based on results from a late-stage trial, where nearly 60% of patients treated with Fasenra...
Merck Secures FDA Approval for Keytruda Combination Therapy as Malignant Pleural Mesothelioma Treatment
Merck Secures FDA Approval for Keytruda Combination Therapy as Malignant Pleural Mesothelioma Treatment
Sep 21, 2024
07:20 AM EDT, 09/18/2024 (MT Newswires) -- Merck ( MRK ) said Wednesday that the US Food and Drug Administration has approved Keytruda's combination with emetrexed and platinum chemotherapy as first-line treatment for adult patients with unresectable advanced or metastatic malignant pleural mesothelioma. The company said the approval was based on data from a phase 2/3 trial, where the combination...
Copyright 2023-2026 - www.financetom.com All Rights Reserved